
SQZ Biotechnologies Company (SQZ) Stock Overview
Explore SQZ Biotechnologies Company’s financial performance, market position, analyst ratings, and future outlook.
SQZ Biotechnologies Company (SQZ)
Key Financials
Key Financials
Market Cap
12.8M
P/E Ratio
-0.16
EPS (TTM)
$-2.16
ROE
-0.86%
SQZ Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of SQZ Biotechnologies Company (NYSE: SQZ) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, SQZ Biotechnologies Company's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SQZ on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $1.98 for the NYSE listing.
Key metrics behind SQZ Biotechnologies Company's NYSE-traded stock include a P/E ratio of -0.16 and a market capitalization of 12.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SQZ on the NYSE.